DarioHealth Corp. filed a current report on November 6, 2026, disclosing that its Board of Directors appointed John R. Palumbo as Chairman of the Board, effective November 3, 2026.

Key Highlights

  • New Chairman: John R. Palumbo was appointed Chairman of the Board of DarioHealth Corp., effective November 3, 2026.
  • Predecessor remains on Board: Yoav Shaked, who previously served as Chairman, will continue as a member of the Board following the transition.
  • Nominating Committee recommendation: The appointment was made on the recommendation of the Nominating Committee of the Board of Directors.
  • Signing officer: The filing was signed by Chen Franco-Yehuda, Chief Financial Officer, Treasurer and Secretary of DarioHealth Corp.

DarioHealth Board Installs New Chairman After Nominating Committee Review

According to the filing, DarioHealth Corp. (NASDAQ:DRIO), a Delaware-incorporated company headquartered at 322 W 57th St., #33B, New York, New York 10019, disclosed a leadership change at the Board level. On November 3, 2026, following a recommendation by the Nominating Committee of the Board, the Board appointed John R. Palumbo as Chairman of the Board, with the appointment taking effect immediately upon the Board's action.

The filing further states that Yoav Shaked, who had been serving as Chairman prior to this change, will not be departing from the Board. According to the registrant's disclosure, Shaked will continue to serve as a member of the Board following the transition. The filing does not describe any compensatory arrangements associated with Palumbo's appointment as Chairman, nor does it provide additional background on his tenure or prior roles at DarioHealth. The report was submitted under Item 5.02, which covers departures and appointments of directors and certain officers, as well as compensatory arrangements of certain officers.

DarioHealth Corp. lists its common stock, par value $0.0001 per share, on the Nasdaq Capital Market under the trading symbol DRIO. The company is not classified as an emerging growth company, according to the registrant's check-mark indication on the filing cover page.

What Was Disclosed

DarioHealth Corp. reported the November 3, 2026 appointment of John R. Palumbo as Chairman of the Board, succeeding Yoav Shaked, who remains a Board member. The filing was signed by CFO Chen Franco-Yehuda and dated November 6, 2026.